FOXP3 and type 1 diabetes mellitus: However, in patients with type 1 diabetes mellitus (T1DM, a metabolic disease with local (pancreas) systemic inflammation), circulating CD8+Foxp3+Tregs show a decrease, which further decreases the severity and duration of the disease, independent of the patient’s age [272].